| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ATMIN CDKL5 NF1 MAPT WASHC5 PUM2 ROBO1 DMD ODF2 OCLN CDC20 PREX1 | 8.14e-06 | 846 | 63 | 12 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ATMIN CDKL5 NF1 MAPT WASHC5 PUM2 ROBO1 DMD ODF2 OCLN CDC20 PREX1 | 9.94e-06 | 863 | 63 | 12 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.81e-05 | 494 | 63 | 9 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 9.53e-05 | 612 | 63 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.15e-04 | 362 | 63 | 7 | GO:0034504 | |
| GeneOntologyBiologicalProcess | organelle assembly | ATMIN CDKL5 NCOR1 VIPAS39 ALMS1 MAPT WASHC5 FAM161A PUM2 CFAP61 ODF2 CDC20 | 1.47e-04 | 1138 | 63 | 12 | GO:0070925 |
| GeneOntologyCellularComponent | spindle pole | 3.76e-06 | 205 | 66 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | ciliary basal body | 3.48e-05 | 195 | 66 | 6 | GO:0036064 | |
| GeneOntologyCellularComponent | spindle | 1.14e-04 | 471 | 66 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | microtubule organizing center | CDKL5 LATS2 ALMS1 TTC28 FAM161A DTL ODF2 CDC20 TOPORS USH2A RBM39 | 1.31e-04 | 919 | 66 | 11 | GO:0005815 |
| GeneOntologyCellularComponent | somatodendritic compartment | CDKL5 NF1 SHANK2 MAPT WASHC5 DTNB PUM2 ROBO1 PAWR DMD USH2A PREX1 | 4.12e-04 | 1228 | 66 | 12 | GO:0036477 |
| GeneOntologyCellularComponent | axon | 4.55e-04 | 891 | 66 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 4.70e-04 | 48 | 66 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.40e-04 | 451 | 66 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | centrosome | 6.73e-04 | 770 | 66 | 9 | GO:0005813 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.51e-04 | 477 | 66 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.72e-04 | 14 | 66 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | neurofilament | 8.72e-04 | 14 | 66 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 9.80e-04 | 139 | 66 | 4 | GO:0097733 | |
| GeneOntologyCellularComponent | cell leading edge | 9.89e-04 | 500 | 66 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.02e-03 | 503 | 66 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.28e-03 | 523 | 66 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.40e-03 | 153 | 66 | 4 | GO:0097731 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.45e-03 | 18 | 66 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.80e-03 | 20 | 66 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.89e-03 | 560 | 66 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.93e-03 | 78 | 66 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | cilium | 1.97e-03 | 898 | 66 | 9 | GO:0005929 | |
| GeneOntologyCellularComponent | axolemma | 1.98e-03 | 21 | 66 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | nuclear body | 2.04e-03 | 903 | 66 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | centriole | 2.14e-03 | 172 | 66 | 4 | GO:0005814 | |
| GeneOntologyCellularComponent | ciliary transition zone | 2.15e-03 | 81 | 66 | 3 | GO:0035869 | |
| GeneOntologyCellularComponent | costamere | 2.18e-03 | 22 | 66 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | neuron projection membrane | 2.23e-03 | 82 | 66 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.37e-03 | 431 | 66 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | nuclear speck | 2.37e-03 | 431 | 66 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 2.57e-03 | 934 | 66 | 9 | GO:0048471 | |
| GeneOntologyCellularComponent | inclusion body | 2.90e-03 | 90 | 66 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.43e-03 | 196 | 66 | 4 | GO:0097730 | |
| GeneOntologyCellularComponent | inhibitory synapse | 4.30e-03 | 31 | 66 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.39e-03 | 210 | 66 | 4 | GO:0031256 | |
| GeneOntologyCellularComponent | neuronal cell body | 4.64e-03 | 835 | 66 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | nuclear membrane | 4.90e-03 | 349 | 66 | 5 | GO:0031965 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 5.10e-03 | 110 | 66 | 3 | GO:0120111 | |
| GeneOntologyCellularComponent | dendrite | 5.46e-03 | 858 | 66 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 5.53e-03 | 860 | 66 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.58e-03 | 360 | 66 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | growth cone | 7.52e-03 | 245 | 66 | 4 | GO:0030426 | |
| MousePheno | microgliosis | 3.73e-05 | 53 | 50 | 4 | MP:0008918 | |
| MousePheno | increased respiratory system tumor incidence | 3.85e-05 | 107 | 50 | 5 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 3.85e-05 | 107 | 50 | 5 | MP:0008014 | |
| MousePheno | impaired coordination | 4.26e-05 | 478 | 50 | 9 | MP:0001405 | |
| MousePheno | delayed muscle development | 7.49e-05 | 4 | 50 | 2 | MP:0000736 | |
| MousePheno | abnormal chromosome morphology | 8.41e-05 | 126 | 50 | 5 | MP:0003702 | |
| MousePheno | increased lung carcinoma incidence | 1.70e-04 | 78 | 50 | 4 | MP:0008714 | |
| MousePheno | neurodegeneration | 2.32e-04 | 468 | 50 | 8 | MP:0002229 | |
| MousePheno | abnormal chromosome number | 2.48e-04 | 86 | 50 | 4 | MP:0004023 | |
| MousePheno | abnormal RR interval | 2.58e-04 | 160 | 50 | 5 | MP:0010504 | |
| MousePheno | abnormal microglial cell morphology | 2.59e-04 | 87 | 50 | 4 | MP:0000136 | |
| MousePheno | abnormal Sertoli cell barrier morphology | 2.60e-04 | 7 | 50 | 2 | MP:0020355 | |
| MousePheno | enhanced long-term object recognition memory | 2.60e-04 | 7 | 50 | 2 | MP:0014368 | |
| MousePheno | gliosis | 3.51e-04 | 171 | 50 | 5 | MP:0002183 | |
| MousePheno | abnormal social investigation | 3.51e-04 | 171 | 50 | 5 | MP:0001360 | |
| MousePheno | seminiferous tubule degeneration | 3.78e-04 | 96 | 50 | 4 | MP:0001154 | |
| MousePheno | neuron degeneration | 4.49e-04 | 391 | 50 | 7 | MP:0003224 | |
| MousePheno | abnormal cell nucleus morphology | 4.91e-04 | 184 | 50 | 5 | MP:0003111 | |
| Domain | PDZ | 1.50e-05 | 148 | 67 | 6 | SM00228 | |
| Domain | - | 1.62e-05 | 150 | 67 | 6 | 2.30.42.10 | |
| Domain | PDZ | 1.68e-05 | 151 | 67 | 6 | PS50106 | |
| Domain | PDZ | 1.74e-05 | 152 | 67 | 6 | IPR001478 | |
| Domain | SH3 | 1.24e-04 | 216 | 67 | 6 | PS50002 | |
| Domain | SH3_domain | 1.37e-04 | 220 | 67 | 6 | IPR001452 | |
| Domain | PDZ | 1.51e-04 | 141 | 67 | 5 | PF00595 | |
| Domain | EF-hand_dom_typ1 | 1.88e-04 | 6 | 67 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.88e-04 | 6 | 67 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.88e-04 | 6 | 67 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.88e-04 | 6 | 67 | 2 | PF09069 | |
| Domain | SH3 | 1.07e-03 | 216 | 67 | 5 | SM00326 | |
| Domain | ZZ | 1.87e-03 | 18 | 67 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.87e-03 | 18 | 67 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.87e-03 | 18 | 67 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.08e-03 | 19 | 67 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.08e-03 | 19 | 67 | 2 | SM00291 | |
| Domain | zf-RanBP | 2.80e-03 | 22 | 67 | 2 | PF00641 | |
| Domain | SH3_1 | 2.86e-03 | 164 | 67 | 4 | PF00018 | |
| Domain | Actinin_actin-bd_CS | 3.06e-03 | 23 | 67 | 2 | IPR001589 | |
| Domain | ZnF_RBZ | 3.06e-03 | 23 | 67 | 2 | SM00547 | |
| Domain | Spectrin | 3.06e-03 | 23 | 67 | 2 | PF00435 | |
| Domain | ZF_RANBP2_2 | 3.06e-03 | 23 | 67 | 2 | PS50199 | |
| Domain | ACTININ_2 | 3.06e-03 | 23 | 67 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.06e-03 | 23 | 67 | 2 | PS00019 | |
| Domain | ZF_RANBP2_1 | 3.33e-03 | 24 | 67 | 2 | PS01358 | |
| Domain | Znf_C3HC4_RING-type | 3.39e-03 | 172 | 67 | 4 | IPR018957 | |
| Domain | Znf_RanBP2 | 3.61e-03 | 25 | 67 | 2 | IPR001876 | |
| Domain | SH3_2 | 3.65e-03 | 86 | 67 | 3 | IPR011511 | |
| Domain | SH3_2 | 3.65e-03 | 86 | 67 | 3 | PF07653 | |
| Domain | Spectrin_repeat | 4.84e-03 | 29 | 67 | 2 | IPR002017 | |
| Domain | - | 5.41e-03 | 449 | 67 | 6 | 3.30.40.10 | |
| Domain | Spectrin/alpha-actinin | 5.87e-03 | 32 | 67 | 2 | IPR018159 | |
| Domain | SPEC | 5.87e-03 | 32 | 67 | 2 | SM00150 | |
| Domain | Znf_RING/FYVE/PHD | 6.01e-03 | 459 | 67 | 6 | IPR013083 | |
| Domain | Znf_RING | 6.27e-03 | 326 | 67 | 5 | IPR001841 | |
| Pubmed | RANBP2 LATS2 ALMS1 TTC28 PPP1R13B OCLN SIPA1L2 NUP153 AHNAK2 | 2.35e-09 | 263 | 68 | 9 | 34702444 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NF1 DST ALMS1 TTC28 MAPT SRGAP1 COBLL1 DTL SRSF11 CDC20 SIPA1L2 MEX3B AHNAK2 | 1.07e-08 | 861 | 68 | 13 | 36931259 |
| Pubmed | 1.27e-07 | 418 | 68 | 9 | 34709266 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOR1 ALMS1 TTC28 DTL PPP1R13B HUWE1 CDC20 SIPA1L2 TOPORS RBM20 | 2.13e-07 | 588 | 68 | 10 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOR1 RANBP2 NF1 SFSWAP MAPT PUM2 RIMS1 HUWE1 ODF2 TOPORS NUP153 | 2.99e-07 | 774 | 68 | 11 | 15302935 |
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 5.95e-07 | 9 | 68 | 3 | 23144817 | |
| Pubmed | NCOR1 RANBP2 DST LATS2 SHANK2 FAM161A DTNB DTL SRSF11 RIMS1 DMD ODF2 SIPA1L2 PREX1 | 6.29e-07 | 1442 | 68 | 14 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | NCOR1 RANBP2 ALMS1 TTC28 WASHC5 PPP1R13B PAWR ODF2 SIPA1L2 RBM39 PDZRN3 | 7.77e-07 | 853 | 68 | 11 | 28718761 |
| Pubmed | NCOR1 RANBP2 VIPAS39 WASHC5 DTNB PPP1R13B ROBO1 HUWE1 DMD ODF2 RBM20 NUP153 | 8.19e-07 | 1049 | 68 | 12 | 27880917 | |
| Pubmed | 1.57e-06 | 733 | 68 | 10 | 34672954 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 DST WWOX ALMS1 RBM27 FARSB PUM2 SIPA1L2 RBM39 NUP153 AHNAK2 | 1.87e-06 | 934 | 68 | 11 | 33916271 |
| Pubmed | CDKL5 RANBP2 VIPAS39 NF1 SHANK2 MAPT WASHC5 RIMS1 HUWE1 SIPA1L2 TRIM29 RBM39 | 1.93e-06 | 1139 | 68 | 12 | 36417873 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.34e-06 | 440 | 68 | 8 | 34244565 | |
| Pubmed | NCOR1 RANBP2 NF1 DST SHANK2 PELP1 EBF3 FARSB RIMS1 HUWE1 NUP153 | 2.51e-06 | 963 | 68 | 11 | 28671696 | |
| Pubmed | 2.59e-06 | 446 | 68 | 8 | 24255178 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28513807 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35098363 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33955002 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19048289 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18984154 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15126504 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16943417 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9395493 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.45e-06 | 123 | 68 | 5 | 26912792 | |
| Pubmed | 4.87e-06 | 486 | 68 | 8 | 20936779 | ||
| Pubmed | NCOR1 RANBP2 SFSWAP PELP1 RBM27 WASHC5 SRSF11 AHDC1 RBM39 NUP153 | 5.65e-06 | 847 | 68 | 10 | 35850772 | |
| Pubmed | 6.26e-06 | 503 | 68 | 8 | 16964243 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN NCOR1 DST LATS2 SHANK2 HUWE1 SLC45A1 SIPA1L2 PREX1 AHDC1 AHNAK2 | 9.26e-06 | 1105 | 68 | 11 | 35748872 |
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 9.33e-06 | 67 | 68 | 4 | 22321011 | |
| Pubmed | 9.64e-06 | 708 | 68 | 9 | 39231216 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16540561 | ||
| Pubmed | Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. | 1.13e-05 | 3 | 68 | 2 | 23883001 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21060114 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 32240725 | ||
| Pubmed | beta-dystrobrevin, a member of the dystrophin-related protein family. | 1.13e-05 | 3 | 68 | 2 | 9419360 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.45e-05 | 565 | 68 | 8 | 25468996 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOR1 RANBP2 WWOX SFSWAP PELP1 RBM27 FARSB SRSF11 RBM39 NUP153 | 1.58e-05 | 954 | 68 | 10 | 36373674 |
| Pubmed | 1.86e-05 | 421 | 68 | 7 | 36976175 | ||
| Pubmed | CDKL5 ILDR2 NF1 DST SHANK2 MAPT WASHC5 FARSB RIMS1 DMD SIPA1L2 RBM39 | 1.94e-05 | 1431 | 68 | 12 | 37142655 | |
| Pubmed | 2.01e-05 | 777 | 68 | 9 | 35844135 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 22174692 | ||
| Pubmed | Beta-dystrobrevin interacts directly with kinesin heavy chain in brain. | 2.25e-05 | 4 | 68 | 2 | 14600269 | |
| Pubmed | Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. | 2.25e-05 | 4 | 68 | 2 | 21041411 | |
| Pubmed | Molecular mechanisms of retroviral integration site selection. | 2.25e-05 | 4 | 68 | 2 | 25147212 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 20530487 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 8954775 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 11839768 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VIPAS39 DST WWOX ALMS1 TTC28 DTL PUM2 HUWE1 CDC20 RBM39 RBM20 AHNAK2 | 2.99e-05 | 1496 | 68 | 12 | 32877691 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DST PELP1 RBM27 SRGAP1 FARSB PAWR CDC20 TOPORS TRIM29 RBM39 NUP153 | 3.05e-05 | 1257 | 68 | 11 | 36526897 |
| Pubmed | 3.73e-05 | 191 | 68 | 5 | 31177093 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 28607399 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12894213 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 16730000 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12138183 | ||
| Pubmed | Assembly of multiple dystrobrevin-containing complexes in the kidney. | 3.75e-05 | 5 | 68 | 2 | 10893187 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 22553025 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 23239027 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 26109731 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 7603572 | ||
| Pubmed | A model for cofactor use during HIV-1 reverse transcription and nuclear entry. | 3.75e-05 | 5 | 68 | 2 | 24525292 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.81e-05 | 332 | 68 | 6 | 32786267 | |
| Pubmed | 5.30e-05 | 104 | 68 | 4 | 10470851 | ||
| Pubmed | Myospryn is a novel binding partner for dysbindin in muscle. | 5.62e-05 | 6 | 68 | 2 | 14688250 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 21041410 | ||
| Pubmed | Different dystrophin-like complexes are expressed in neurons and glia. | 5.62e-05 | 6 | 68 | 2 | 10545507 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 11672528 | ||
| Pubmed | The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. | 5.62e-05 | 6 | 68 | 2 | 18487609 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 11266456 | ||
| Pubmed | 5.73e-05 | 209 | 68 | 5 | 36779422 | ||
| Pubmed | 6.14e-05 | 347 | 68 | 6 | 17114649 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 6.28e-05 | 695 | 68 | 8 | 23602568 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 32960816 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 24051001 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 16448387 | ||
| Pubmed | Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. | 7.86e-05 | 7 | 68 | 2 | 10747910 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21655271 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21115837 | ||
| Pubmed | Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. | 7.86e-05 | 7 | 68 | 2 | 12192048 | |
| Pubmed | 8.11e-05 | 225 | 68 | 5 | 12168954 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 9.18e-05 | 231 | 68 | 5 | 16452087 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 9.25e-05 | 120 | 68 | 4 | 31413325 | |
| Pubmed | 9.69e-05 | 547 | 68 | 7 | 37267103 | ||
| Pubmed | 9.75e-05 | 234 | 68 | 5 | 36243803 | ||
| Pubmed | Roles of HIV-1 capsid in viral replication and immune evasion. | 1.05e-04 | 8 | 68 | 2 | 25036886 | |
| Pubmed | A genome-wide association study of clinical symptoms of dissociation in a trauma-exposed sample. | 1.05e-04 | 8 | 68 | 2 | 24677629 | |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 1.05e-04 | 8 | 68 | 2 | 31375530 | |
| Pubmed | 1.23e-04 | 246 | 68 | 5 | 15345747 | ||
| Pubmed | 1.26e-04 | 130 | 68 | 4 | 12421765 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.28e-04 | 989 | 68 | 9 | 36424410 | |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 1.31e-04 | 50 | 68 | 3 | 19807924 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 9114010 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN LATS2 WWOX SHANK2 MAPT DTNB SRSF11 RIMS1 HUWE1 AHDC1 RBM39 | 1.39e-04 | 1489 | 68 | 11 | 28611215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.42e-04 | 582 | 68 | 7 | 20467437 | |
| Pubmed | RANBP2 ZCCHC9 DST SHANK2 SFSWAP RBM27 FARSB PUM2 ODF2 PREX1 AHDC1 | 1.45e-04 | 1497 | 68 | 11 | 31527615 | |
| Pubmed | NCOR1 RANBP2 FARSB SRSF11 PAWR HUWE1 CDC20 TOPORS AHDC1 RBM39 | 1.49e-04 | 1247 | 68 | 10 | 27684187 | |
| Pubmed | 1.56e-04 | 591 | 68 | 7 | 15231748 | ||
| Pubmed | High-throughput mapping of a dynamic signaling network in mammalian cells. | 1.59e-04 | 260 | 68 | 5 | 15761153 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.67e-04 | 1024 | 68 | 9 | 24711643 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 30348677 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 27581360 | ||
| Interaction | CEP128 interactions | LATS2 ALMS1 MAPT WASHC5 DTNB PPP1R13B PAWR ODF2 CDC20 SIPA1L2 | 4.91e-08 | 297 | 67 | 10 | int:CEP128 |
| Interaction | LZTS2 interactions | LATS2 WWOX ALMS1 TTC28 SH3RF2 FAM161A PPP1R13B HUWE1 ODF2 OCLN SIPA1L2 TRIM29 | 1.07e-07 | 512 | 67 | 12 | int:LZTS2 |
| Interaction | NINL interactions | NCOR1 LATS2 ALMS1 TTC28 FAM161A PPP1R13B HUWE1 ODF2 CDC20 SIPA1L2 RBM39 | 3.03e-07 | 458 | 67 | 11 | int:NINL |
| Interaction | PPP1CA interactions | CDKL5 NCOR1 WWOX MAPT SH3RF2 PPP1R13B SRSF11 PAWR HUWE1 SLC45A1 PREX1 RBM39 NUP153 | 4.04e-07 | 696 | 67 | 13 | int:PPP1CA |
| Interaction | YWHAH interactions | NF1 DST LATS2 ALMS1 SFSWAP TTC28 MAPT SRGAP1 COBLL1 DTL RIMS1 HUWE1 CDC20 SIPA1L2 MEX3B AHNAK2 | 4.59e-07 | 1102 | 67 | 16 | int:YWHAH |
| Interaction | YWHAG interactions | NF1 DST LATS2 ALMS1 TTC28 MAPT SRGAP1 COBLL1 DTL SRSF11 PAWR HUWE1 CDC20 SIPA1L2 MEX3B AHNAK2 | 2.37e-06 | 1248 | 67 | 16 | int:YWHAG |
| Interaction | YWHAZ interactions | NCOR1 NF1 DST LATS2 WWOX TTC28 COL6A6 RBM27 MAPT SRGAP1 COBLL1 DTL HUWE1 SIPA1L2 MEX3B RBM39 | 4.83e-06 | 1319 | 67 | 16 | int:YWHAZ |
| Interaction | KIAA1549 interactions | 9.87e-06 | 86 | 67 | 5 | int:KIAA1549 | |
| Interaction | KDM1A interactions | NCOR1 RANBP2 DST WWOX ALMS1 ZNF280D PELP1 TTC28 MAPT FAM161A HUWE1 RBM39 RBM20 | 1.12e-05 | 941 | 67 | 13 | int:KDM1A |
| Interaction | RNF43 interactions | RANBP2 LATS2 ALMS1 TTC28 PPP1R13B OCLN SIPA1L2 NUP153 AHNAK2 | 1.14e-05 | 427 | 67 | 9 | int:RNF43 |
| Interaction | BRCA1 interactions | NF1 DST WWOX ALMS1 ZNF280D TTC28 MAPT FAM161A PPP1R13B FARSB HUWE1 ODF2 TRIM29 USH2A NUP153 | 1.15e-05 | 1249 | 67 | 15 | int:BRCA1 |
| Interaction | AFDN interactions | 1.43e-05 | 333 | 67 | 8 | int:AFDN | |
| Interaction | TNIK interactions | 3.74e-05 | 381 | 67 | 8 | int:TNIK | |
| Interaction | ARPP19 interactions | 3.84e-05 | 20 | 67 | 3 | int:ARPP19 | |
| Interaction | DVL3 interactions | 3.96e-05 | 280 | 67 | 7 | int:DVL3 | |
| Interaction | SIPA1L3 interactions | 4.57e-05 | 118 | 67 | 5 | int:SIPA1L3 | |
| Interaction | TJP2 interactions | 4.73e-05 | 288 | 67 | 7 | int:TJP2 | |
| Interaction | IKZF5 interactions | 6.48e-05 | 65 | 67 | 4 | int:IKZF5 | |
| Interaction | DYRK1A interactions | 8.45e-05 | 552 | 67 | 9 | int:DYRK1A | |
| Interaction | TJP1 interactions | 1.01e-04 | 325 | 67 | 7 | int:TJP1 | |
| Interaction | EPHA2 interactions | 1.24e-04 | 719 | 67 | 10 | int:EPHA2 | |
| Interaction | LYN interactions | 1.25e-04 | 720 | 67 | 10 | int:LYN | |
| Interaction | ANKFY1 interactions | 1.33e-04 | 236 | 67 | 6 | int:ANKFY1 | |
| Interaction | PHF21A interactions | 1.41e-04 | 343 | 67 | 7 | int:PHF21A | |
| Interaction | SUMO2 interactions | 1.42e-04 | 591 | 67 | 9 | int:SUMO2 | |
| Interaction | LCK interactions | 1.45e-04 | 463 | 67 | 8 | int:LCK | |
| Interaction | DVL1 interactions | 1.47e-04 | 151 | 67 | 5 | int:DVL1 | |
| Interaction | GSK3A interactions | 1.47e-04 | 464 | 67 | 8 | int:GSK3A | |
| Interaction | ARHGEF7 interactions | 1.56e-04 | 153 | 67 | 5 | int:ARHGEF7 | |
| Interaction | CPVL interactions | 1.71e-04 | 156 | 67 | 5 | int:CPVL | |
| Interaction | LZTS3 interactions | 1.78e-04 | 33 | 67 | 3 | int:LZTS3 | |
| Interaction | NIN interactions | 1.86e-04 | 359 | 67 | 7 | int:NIN | |
| Interaction | NUP43 interactions | 2.15e-04 | 625 | 67 | 9 | int:NUP43 | |
| Interaction | RCOR1 interactions | 2.26e-04 | 494 | 67 | 8 | int:RCOR1 | |
| Interaction | RHBDF2 interactions | 2.41e-04 | 168 | 67 | 5 | int:RHBDF2 | |
| Interaction | CEP85 interactions | 2.48e-04 | 169 | 67 | 5 | int:CEP85 | |
| Interaction | SIPA1L1 interactions | 2.84e-04 | 174 | 67 | 5 | int:SIPA1L1 | |
| Interaction | MARK2 interactions | 2.98e-04 | 274 | 67 | 6 | int:MARK2 | |
| Interaction | PPP1R13B interactions | 2.99e-04 | 176 | 67 | 5 | int:PPP1R13B | |
| Interaction | APC interactions | 3.04e-04 | 389 | 67 | 7 | int:APC | |
| Interaction | CEP63 interactions | 3.23e-04 | 179 | 67 | 5 | int:CEP63 | |
| Interaction | ARL8A interactions | 3.31e-04 | 99 | 67 | 4 | int:ARL8A | |
| Interaction | TNRC6B interactions | 3.47e-04 | 282 | 67 | 6 | int:TNRC6B | |
| Interaction | HSPA4 interactions | 3.48e-04 | 667 | 67 | 9 | int:HSPA4 | |
| Interaction | NAA40 interactions | RANBP2 DST WWOX ALMS1 RBM27 FARSB PUM2 SIPA1L2 RBM39 NUP153 AHNAK2 | 3.52e-04 | 978 | 67 | 11 | int:NAA40 |
| Interaction | NUP160 interactions | 3.58e-04 | 183 | 67 | 5 | int:NUP160 | |
| Interaction | GOLGA1 interactions | 3.58e-04 | 183 | 67 | 5 | int:GOLGA1 | |
| Interaction | ERC1 interactions | 3.95e-04 | 187 | 67 | 5 | int:ERC1 | |
| Interaction | FXR1 interactions | 3.96e-04 | 679 | 67 | 9 | int:FXR1 | |
| Interaction | ENTR1 interactions | 4.05e-04 | 188 | 67 | 5 | int:ENTR1 | |
| Interaction | FASLG interactions | 4.14e-04 | 105 | 67 | 4 | int:FASLG | |
| Interaction | RAB10 interactions | 4.25e-04 | 190 | 67 | 5 | int:RAB10 | |
| Interaction | IPO5 interactions | 4.42e-04 | 414 | 67 | 7 | int:IPO5 | |
| Interaction | PARD3 interactions | 4.65e-04 | 298 | 67 | 6 | int:PARD3 | |
| Interaction | UBAP2L interactions | 4.65e-04 | 298 | 67 | 6 | int:UBAP2L | |
| Interaction | YWHAB interactions | VIPAS39 NF1 DST TTC28 MAPT SRGAP1 COBLL1 DTL SIPA1L2 MEX3B AHNAK2 | 4.78e-04 | 1014 | 67 | 11 | int:YWHAB |
| Interaction | TARS1 interactions | 4.79e-04 | 195 | 67 | 5 | int:TARS1 | |
| Interaction | EZR interactions | 4.80e-04 | 553 | 67 | 8 | int:EZR | |
| Interaction | YTHDF1 interactions | 4.99e-04 | 302 | 67 | 6 | int:YTHDF1 | |
| Interaction | NUP35 interactions | 5.09e-04 | 424 | 67 | 7 | int:NUP35 | |
| Interaction | SYNGAP1 interactions | 5.44e-04 | 307 | 67 | 6 | int:SYNGAP1 | |
| Interaction | CAPZA2 interactions | 5.54e-04 | 430 | 67 | 7 | int:CAPZA2 | |
| Interaction | KCNA3 interactions | 5.73e-04 | 871 | 67 | 10 | int:KCNA3 | |
| Interaction | LHX5 interactions | 5.87e-04 | 11 | 67 | 2 | int:LHX5 | |
| Interaction | JMJD6 interactions | 6.01e-04 | 205 | 67 | 5 | int:JMJD6 | |
| Interaction | MSH2 interactions | 6.03e-04 | 313 | 67 | 6 | int:MSH2 | |
| GeneFamily | PDZ domain containing | 3.75e-06 | 152 | 50 | 6 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.02e-05 | 181 | 50 | 6 | 694 | |
| GeneFamily | Ring finger proteins | 9.51e-04 | 275 | 50 | 5 | 58 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-03 | 18 | 50 | 2 | 91 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.52e-03 | 21 | 50 | 2 | 89 | |
| GeneFamily | RNA binding motif containing | 2.82e-03 | 213 | 50 | 4 | 725 | |
| GeneFamily | Nucleoporins | 3.53e-03 | 32 | 50 | 2 | 1051 | |
| GeneFamily | Collagens | 7.18e-03 | 46 | 50 | 2 | 490 | |
| GeneFamily | Fibronectin type III domain containing | 9.83e-03 | 160 | 50 | 3 | 555 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.49e-05 | 97 | 68 | 5 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_500 | 1.55e-05 | 47 | 68 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 2.62e-05 | 109 | 68 | 5 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ILDR2 WWOX ALMS1 SFSWAP DTNB SPDYA SRSF11 HUWE1 MEX3B RBM39 NUP153 | 3.31e-05 | 776 | 68 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | NCOR1 DST FAM161A ROBO1 PAWR HUWE1 DMD ODF2 OCLN TRIM29 PDZRN3 | 4.37e-05 | 800 | 68 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_200 | 5.31e-05 | 23 | 68 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.72e-05 | 210 | 68 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.10e-05 | 311 | 68 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | ILDR2 TTC28 EBF3 SH3RF2 RIMS1 SLC45A1 DMD MYO15A SIPA1L2 AHDC1 RBM20 | 7.38e-05 | 848 | 68 | 11 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.51e-05 | 328 | 68 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.08e-04 | 29 | 68 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.60e-04 | 85 | 68 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.30e-04 | 654 | 68 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ILDR2 NCOR1 RANBP2 ALMS1 ZNF280D SRGAP1 IGDCC3 SRSF11 PAWR DMD ODF2 | 2.84e-04 | 989 | 68 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 2.86e-04 | 827 | 68 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.26e-04 | 186 | 68 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.38e-04 | 291 | 68 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.77e-04 | 192 | 68 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.63e-10 | 193 | 69 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.22e-08 | 195 | 69 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.22e-08 | 195 | 69 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-08 | 198 | 69 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.55e-08 | 199 | 69 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-08 | 200 | 69 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-08 | 200 | 69 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-07 | 162 | 69 | 6 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-07 | 162 | 69 | 6 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.59e-07 | 187 | 69 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.59e-07 | 187 | 69 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.73e-07 | 188 | 69 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.52e-07 | 193 | 69 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.52e-07 | 193 | 69 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.86e-07 | 195 | 69 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.22e-07 | 197 | 69 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.41e-07 | 198 | 69 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.41e-07 | 198 | 69 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.60e-07 | 199 | 69 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-07 | 199 | 69 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.60e-07 | 199 | 69 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.80e-07 | 200 | 69 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.80e-07 | 200 | 69 | 6 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-07 | 200 | 69 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-07 | 200 | 69 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.80e-07 | 200 | 69 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-07 | 200 | 69 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 5.15e-06 | 161 | 69 | 5 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.98e-06 | 166 | 69 | 5 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-06 | 169 | 69 | 5 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-06 | 175 | 69 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-06 | 180 | 69 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 181 | 69 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.10e-06 | 181 | 69 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.10e-06 | 181 | 69 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.85e-06 | 184 | 69 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 185 | 69 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.06e-05 | 187 | 69 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.06e-05 | 187 | 69 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.09e-05 | 188 | 69 | 5 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 188 | 69 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 188 | 69 | 5 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.12e-05 | 189 | 69 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.12e-05 | 189 | 69 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-05 | 189 | 69 | 5 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 189 | 69 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.15e-05 | 190 | 69 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-05 | 190 | 69 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.15e-05 | 190 | 69 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.15e-05 | 190 | 69 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 191 | 69 | 5 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 191 | 69 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.18e-05 | 191 | 69 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 191 | 69 | 5 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 191 | 69 | 5 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-05 | 191 | 69 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 192 | 69 | 5 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-05 | 192 | 69 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 192 | 69 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.21e-05 | 192 | 69 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-05 | 193 | 69 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 69 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 69 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 193 | 69 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 194 | 69 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-05 | 194 | 69 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 194 | 69 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 194 | 69 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 69 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-05 | 194 | 69 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 195 | 69 | 5 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 195 | 69 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 195 | 69 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 195 | 69 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 196 | 69 | 5 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 196 | 69 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-05 | 196 | 69 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 197 | 69 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.40e-05 | 198 | 69 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 198 | 69 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 198 | 69 | 5 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-05 | 198 | 69 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 69 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 200 | 69 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-05 | 127 | 69 | 4 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.60e-05 | 154 | 69 | 4 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.84e-05 | 155 | 69 | 4 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-04 | 157 | 69 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 158 | 69 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 158 | 69 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 159 | 69 | 4 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.09e-04 | 159 | 69 | 4 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.11e-04 | 160 | 69 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| Computational | Intermediate filaments and MT. | 1.24e-04 | 68 | 41 | 4 | MODULE_438 | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.24e-06 | 197 | 69 | 7 | 6792_DN | |
| Drug | halofuginone lactate | 6.00e-06 | 85 | 69 | 5 | CID000062891 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.73e-05 | 152 | 68 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | respiratory failure, COVID-19 | 4.10e-05 | 29 | 68 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | retinal detachment, retinal break | 7.27e-05 | 35 | 68 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Disorder of eye | 1.32e-04 | 212 | 68 | 5 | C0015397 | |
| Disease | Urologic Neoplasms | 1.45e-04 | 8 | 68 | 2 | C0042076 | |
| Disease | Cancer of Urinary Tract | 1.45e-04 | 8 | 68 | 2 | C0751571 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.82e-04 | 157 | 68 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | urate measurement, bone density | 5.54e-04 | 619 | 68 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Retinitis pigmentosa | 6.75e-04 | 74 | 68 | 3 | cv:C0035334 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 7.82e-04 | 18 | 68 | 2 | EFO_0010365 | |
| Disease | Splenomegaly | 1.17e-03 | 22 | 68 | 2 | C0038002 | |
| Disease | breast cancer, COVID-19 | 1.17e-03 | 22 | 68 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.31e-03 | 93 | 68 | 3 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.52e-03 | 25 | 68 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 1.77e-03 | 27 | 68 | 2 | C0334579 | |
| Disease | Retinitis Pigmentosa | 1.81e-03 | 104 | 68 | 3 | C0035334 | |
| Disease | facial width measurement | 1.86e-03 | 105 | 68 | 3 | EFO_0007855 | |
| Disease | bone density | 2.03e-03 | 388 | 68 | 5 | EFO_0003923 | |
| Disease | Developmental Academic Disorder | 2.04e-03 | 29 | 68 | 2 | C1330966 | |
| Disease | Learning Disorders | 2.04e-03 | 29 | 68 | 2 | C0023186 | |
| Disease | Learning Disturbance | 2.04e-03 | 29 | 68 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 2.04e-03 | 29 | 68 | 2 | C0751262 | |
| Disease | Learning Disabilities | 2.04e-03 | 29 | 68 | 2 | C0751265 | |
| Disease | alcohol consumption measurement | 2.13e-03 | 1242 | 68 | 9 | EFO_0007878 | |
| Disease | intellectual disability (is_implicated_in) | 2.18e-03 | 30 | 68 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | forced expiratory volume | 2.24e-03 | 789 | 68 | 7 | EFO_0004314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQPFSKPGYITNSSR | 121 | Q6N043 | |
| ATPGSSRKTCRYIPS | 156 | Q12834 | |
| YSASFTTPTKPFRLQ | 916 | Q8NHU2 | |
| DRKTGIPTLPSTFYS | 1416 | Q8TCU4 | |
| SLAQGYERTSSPKPR | 281 | P11532 | |
| PIASKSFLYPGSSTR | 256 | Q9NZJ0 | |
| AASGYPSKRSTGPRQ | 1256 | Q5TGY3 | |
| RSRGSPSSTCVPYKV | 41 | A6NI87 | |
| HRPTFTRSNTISKPY | 266 | Q53SF7 | |
| SPRKGPQTVNSSSIY | 566 | Q96KQ4 | |
| YIASVQGSTPSPRQK | 11 | P49792 | |
| NLGTSYVPIPARSFT | 481 | Q5T481 | |
| PEAPSITSSGRSQYR | 491 | Q9P2N5 | |
| SRSPTPSQKLGSAYL | 846 | Q9UPQ7 | |
| RSPYSGPKFNSAIRG | 96 | Q14498 | |
| QEPPRTVSGRYKSTT | 216 | Q96IZ0 | |
| PRYSSGGNFETPSKR | 366 | Q16625 | |
| KRSSSSLAPIGQPFY | 596 | Q8TB72 | |
| YQTFPSGKRVSPQER | 176 | A6NJV1 | |
| LFYRPASKTSFTGPI | 556 | Q8IVU1 | |
| GYGVQRSPSFQSKTP | 266 | Q9NRM7 | |
| YLKGLFSSVPASRPS | 3321 | Q9UKN7 | |
| RKRFPASSLYPSGSQ | 7121 | Q03001 | |
| PKQRRSFGSFPYTPS | 1356 | Q2LD37 | |
| RYTAGSASPTPTFKT | 2596 | Q2LD37 | |
| RTSPYPGSKVERSQV | 66 | Q9BW91 | |
| TVYRGDKSQASRPTP | 76 | O15527 | |
| LSPGQERPYSTVRTK | 416 | Q8IZL8 | |
| FRTSPGDRVTYTINP | 4081 | Q7Z6Z7 | |
| VPPVGYRSSARESKS | 921 | Q86UR5 | |
| GSNTDKQTLTTPPRY | 276 | O43313 | |
| SPPGSAASKRARTAY | 181 | P14651 | |
| RGPTSAVTKARTSYP | 91 | Q6ZV80 | |
| GLPPSYVFVSTQRFK | 276 | Q96P44 | |
| SSGVPTPTKRLQYSQ | 351 | O60941 | |
| SGRPISPRSSVNSSY | 456 | Q8NA82 | |
| SRNTSSVSPRGYVPS | 461 | Q9H4W6 | |
| KARPIPRSTYGSTTN | 356 | Q3B820 | |
| DTIPQSSRSPSYRTK | 471 | O76039 | |
| SPLTPKYGSFISRDS | 376 | Q9Y2W3 | |
| SFVSQYFSPTKGARP | 706 | A6NMZ7 | |
| YAQTLSKTPGLPSFR | 191 | Q96QI5 | |
| GPYSTFLTSSPIRSR | 811 | Q5BJF6 | |
| SITPTPGRKPFSSYR | 271 | Q6ZN04 | |
| PGRKPFSSYRNDSSS | 276 | Q6ZN04 | |
| SVPTPSRVRSLNGYS | 1956 | O75445 | |
| PPTVTVYVKSGSNRS | 11 | Q5MJ70 | |
| PTAYRVSRSPGASRK | 826 | Q12872 | |
| VRTSYQPSSPGRFTK | 481 | Q14134 | |
| DSPPIRRSTSSGQYT | 931 | Q7Z6B7 | |
| TPVRTKTSNRYSPES | 2091 | O75376 | |
| YPKTTPSVGRSFSIR | 981 | Q8TCU6 | |
| GTPCEYKTPFRRNTT | 1051 | Q9P2F8 | |
| PQVYRTTSPPFGKTT | 241 | P21815 | |
| TLSGPFTYTAKRPSD | 166 | Q9NSD9 | |
| AKTIGSYVPGPRSRS | 461 | Q9UPX8 | |
| PSYRASAPGKSIQAS | 3316 | Q8IVF2 | |
| RSTGYSSQPGAKRPS | 191 | Q12768 | |
| SRSPNKQSGYSRPRA | 596 | B3KS81 | |
| PPKSYSTARRSRSAS | 326 | Q05519 | |
| PSKRSAQLGPRSASY | 551 | Q71H61 | |
| ATYPTVGQTSPRARK | 2506 | P21359 | |
| DNPTKPTTRQRYDGS | 96 | Q9NZC7 | |
| PSSPKYVSSVTSRTG | 436 | P10636 | |
| TYAGIRKVPSFTFTP | 931 | Q9Y6N7 | |
| PKPTSTYSLSSFFRG | 101 | Q9H9C1 | |
| ATNRSVYFKPSLTPS | 376 | P49790 | |
| PARSSSLPKVSSGYS | 2236 | Q96AY4 | |
| SVYSPSGPVNRRTTT | 191 | Q9NS56 | |
| RVSTTYNKRPLPATS | 6 | Q8N567 | |
| RKTSSFPDSRSPGLY | 441 | Q8TEC5 | |
| LSPQVSSSVVYGRSP | 376 | Q04725 | |
| TFHSSPGYTKTTRLP | 366 | Q9UKN1 | |
| PGYTKTTRLPDNTTT | 371 | Q9UKN1 |